Terms: = Leukemia AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
73 results:
1. Clinical presentation of childhood soft tissue sarcomas: a systematic review and meta-analysis.
Ni Cheallaigh L; Liu JF; Fern L; Winyard P; Walker D; Ball-Gamble A; Shanmugavadivel D
Arch Dis Child; 2024 Jan; 109(2):113-120. PubMed ID: 37857451
[TBL] [Abstract] [Full Text] [Related]
2. Gallium(III)- and Thallium(III)-Encapsulated Polyoxopalladates: Synthesis, Structure, Multinuclear NMR, and Biological Activity Studies.
Ma T; Ma X; Lin Z; Zhang J; Yang P; Csupász T; Tóth I; Misirlic-Dencic S; Isakovic AM; Lembo D; Donalisio M; Kortz U
Inorg Chem; 2023 Aug; 62(33):13195-13204. PubMed ID: 37555777
[TBL] [Abstract] [Full Text] [Related]
3. Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Lu X; Emond B; Qureshi ZP; Wu LH; Forbes SP; Hilts A; Liu S; Lafeuille MH; Lefebvre P; Huang Q; Rogers KA
Curr Med Res Opin; 2023 Sep; 39(9):1227-1235. PubMed ID: 37530387
[TBL] [Abstract] [Full Text] [Related]
4. Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia.
Roeker LE; DerSarkissian M; Ryan K; Chen Y; Duh MS; Wahlstrom SK; Hakre S; Yu L; Guo H; Mato AR
Blood Adv; 2023 Aug; 7(16):4291-4301. PubMed ID: 37163361
[TBL] [Abstract] [Full Text] [Related]
5. Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
Atallah E; Mauro MJ; Hochhaus A; Boquimpani C; Minami Y; Maheshwari VK; Saini L; Corbin R; Réa D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6247-6262. PubMed ID: 36707445
[TBL] [Abstract] [Full Text] [Related]
6. Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.
Narezkina A; Akhter N; Lu X; Emond B; Panjabi S; Forbes SP; Hilts A; Liu S; Lafeuille MH; Lefebvre P; Huang Q; Choi M
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):e959-e971. PubMed ID: 35973891
[TBL] [Abstract] [Full Text] [Related]
7. Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse.
Berdel AF; Ruhnke L; Angenendt L; Wermke M; Röllig C; Mikesch JH; Scheller A; Hemmerle T; Matasci M; Wethmar K; Kessler T; Gerwing M; Hescheler D; Schäfers M; Hartmann W; Altvater B; Rossig C; Bornhäuser M; Lenz G; Stelljes M; Rueter B; Neri D; Berdel WE; Schliemann C
Blood Adv; 2022 Jun; 6(12):3684-3696. PubMed ID: 35468621
[TBL] [Abstract] [Full Text] [Related]
8. Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.
Pratz KW; Panayiotidis P; Recher C; Wei X; Jonas BA; Montesinos P; Ivanov V; Schuh AC; DiNardo CD; Novak J; Pejsa V; Stevens D; Yeh SP; Kim I; Turgut M; Fracchiolla N; Yamamoto K; Ofran Y; Wei AH; Bui CN; Benjamin K; Kamalakar R; Potluri J; Mendes W; Devine J; Fiedler W
Blood Cancer J; 2022 Apr; 12(4):71. PubMed ID: 35443742
[TBL] [Abstract] [Full Text] [Related]
9. C-reactive protein trajectories and the risk of all cancer types: A prospective cohort study.
Liu T; Zhang Q; Song C; Siyin ST; Chen S; Zhang Q; Song M; Cao L; Shi H
Int J Cancer; 2022 Jul; 151(2):297-307. PubMed ID: 35368093
[TBL] [Abstract] [Full Text] [Related]
10. Life-threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia-Singapore 2003 and 2010 clinical trials: A risk prediction model.
Oh BLZ; Fan L; Lee SHR; Foo KM; Chiew KH; Seeto ZZL; Chen ZW; Neoh CCC; Liew GSM; Eng JJ; Lam JCM; Quah TC; Tan AM; Chan YH; Yeoh AEJ
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e456-e468. PubMed ID: 35134276
[TBL] [Abstract] [Full Text] [Related]
11. Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit.
Agrawal R; Goel V; Anand A; Arora RS
Pediatr Blood Cancer; 2022 Feb; 69(2):e29462. PubMed ID: 34842336
[TBL] [Abstract] [Full Text] [Related]
12. Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.
Williams L; Doucette K; Karp JE; Lai C
Bone Marrow Transplant; 2021 Jul; 56(7):1535-1549. PubMed ID: 33686252
[TBL] [Abstract] [Full Text] [Related]
13. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
[No Abstract] [Full Text] [Related]
14. Lack of association between functional polymorphism of DNA repair genes (XRCC1, xpd) and clinical response in Indian chronic myeloid leukemia patients.
Dhangar S; Shanbhag V; Shanmukhaiah C; Vundinti BR
Mol Biol Rep; 2019 Oct; 46(5):4997-5003. PubMed ID: 31286393
[TBL] [Abstract] [Full Text] [Related]
15. Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome.
Jindra P; Raida L; Karas M; Szotkowski T; Lysák D; Hrabětová M; Jungová A; Steinerová K; Faber E; Papajík T
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):462-469. PubMed ID: 31109905
[TBL] [Abstract] [Full Text] [Related]
16. Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m
Moreau P; Kumar S; Boccia R; Iida S; Goldschmidt H; Cocks K; Trigg A; Zahlten-Kumeli A; Yucel E; Panjabi SS; Dimopoulos M
Leukemia; 2019 Dec; 33(12):2934-2946. PubMed ID: 31092895
[TBL] [Abstract] [Full Text] [Related]
17. Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
Topp MS; Zimmerman Z; Cannell P; Dombret H; Maertens J; Stein A; Franklin J; Tran Q; Cong Z; Schuh AC
Blood; 2018 Jun; 131(26):2906-2914. PubMed ID: 29739753
[TBL] [Abstract] [Full Text] [Related]
18. Metabolites of endophytic fungi from Australian native plants as potential anticancer agents.
Zaferanloo B; Pepper SA; Coulthard SA; Redfern CPF; Palombo EA
FEMS Microbiol Lett; 2018 May; 365(9):. PubMed ID: 29590360
[TBL] [Abstract] [Full Text] [Related]
19. Thinking out of the
Koh FH; Chan HL; Petersson F; Chong CS
Gut; 2017 Dec; 66(12):2068-2159. PubMed ID: 27965282
[TBL] [Abstract] [Full Text] [Related]
20. Influence of XPC, xpd, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract] [Full Text] [Related]
[Next]
